Skip to main content
Top
Published in: Infection 2/2013

01-04-2013 | Clinical and Epidemiological Study

Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong

Authors: S. S. H. Suen, T. T. Lao, O. K. Chan, T. K. Lau, T. Y. Leung, P. K. S. Chan

Published in: Infection | Issue 2/2013

Login to get access

Abstract

Purpose

To determine the effect of age on the prevalence of hepatitis B virus (HBV) infection during a routine screening programme of first-year students enrolled in Health Sciences Studies at the Chinese University of Hong Kong from 2001 to 2009.

Methods

In a retrospective cohort study, data on the hepatitis B surface antigen (HBsAg) status was retrieved from the University Health Service and analysed according to the age of the student at testing and year of birth.

Results

Of the 2,688 students enrolled in the study group, 79 (2.9 %) tested positive for HBsAg. The prevalence increased significantly from 0.9, 2.3, 4.3 to 5.5 % for those tested at age ≤18, 19, 20 and ≥ 21 years, respectively (p < 0.001). On logistic regression analysis, taking age ≤18 years and year of birth before 1983 (before the availability of HBV vaccination) as the reference group, HBV infection increased progressively with age, with an adjusted odds ratio of 3.36 [95 % confidence interval (CI) 1.01–11.23], 6.04 (95 % CI 1.74–20.98) and 11.61 (95 % CI 3.20–42.13) for age 19, 20 and ≥21 years, respectively. There was no significant change in the odds ratio after adjustment for the year of birth before and after introduction of the vaccination programme.

Conclusion

Among the university students enrolled in our study, the overall prevalence of HBV infection before and after the introduction of HBV vaccination was lower than the 10 % found in the general population. There was, however, a significant progressive increase with age at testing from ≤18 to ≥21 years, suggesting a previously overlooked contribution of horizontal transmission to the high prevalence of HBV infection found in our adult population.
Literature
1.
go back to reference Yeoh EK. Editorial, hepatitis B vaccination—who should be vaccinated? J Hong Kong Med Assoc. 1987;39:208–9. Yeoh EK. Editorial, hepatitis B vaccination—who should be vaccinated? J Hong Kong Med Assoc. 1987;39:208–9.
2.
go back to reference Lee PI, Lee CY, Huang LM, Chen JM, Chang MH. A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants. Vaccine. 1995;13:1685–9.PubMedCrossRef Lee PI, Lee CY, Huang LM, Chen JM, Chang MH. A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants. Vaccine. 1995;13:1685–9.PubMedCrossRef
3.
go back to reference Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099–102.PubMedCrossRef Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099–102.PubMedCrossRef
4.
go back to reference Wong VCW, Ip HMH, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HbeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1:921–6.PubMedCrossRef Wong VCW, Ip HMH, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HbeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1:921–6.PubMedCrossRef
5.
go back to reference Lee SS. Hepatitis B vaccination programme in Hong Kong. Public Health Epidemiol Bull. 1993;2:9–12. Lee SS. Hepatitis B vaccination programme in Hong Kong. Public Health Epidemiol Bull. 1993;2:9–12.
6.
go back to reference Lok ASF. Hepatitis B vaccination in Hong Kong. J Gastroenterol Hepatol. 1993;8:S27–9.CrossRef Lok ASF. Hepatitis B vaccination in Hong Kong. J Gastroenterol Hepatol. 1993;8:S27–9.CrossRef
7.
go back to reference Kwan LC, Ho YY, Lee SS. The declining HbsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect. 1997;119:281–3.PubMedCrossRef Kwan LC, Ho YY, Lee SS. The declining HbsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect. 1997;119:281–3.PubMedCrossRef
9.
go back to reference The Scientific Working Group on Viral Hepatitis Prevention, Department of Health. Recommendations on hepatitis B Vaccination Regimens in Hong Kong—consensus of the scientific working group on viral hepatitis prevention. Hong Kong: Department of Health; 1998. Available at: http://www.chp.gov.hk/files/pdf/hepBreg04.pdf. The Scientific Working Group on Viral Hepatitis Prevention, Department of Health. Recommendations on hepatitis B Vaccination Regimens in Hong Kong—consensus of the scientific working group on viral hepatitis prevention. Hong Kong: Department of Health; 1998. Available at: http://​www.​chp.​gov.​hk/​files/​pdf/​hepBreg04.​pdf.
10.
go back to reference Leung CW. Proceedings of State of Asian children—immunization. HK J Paediatr (New Series). 1999;4:59–62. Leung CW. Proceedings of State of Asian children—immunization. HK J Paediatr (New Series). 1999;4:59–62.
11.
go back to reference Chan OK, Suen SS, Lao TT, Leung VK, Yeung SW, Leung TY. Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong. Int J Gynaecol Obstet. 2009;106:232–5.PubMedCrossRef Chan OK, Suen SS, Lao TT, Leung VK, Yeung SW, Leung TY. Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong. Int J Gynaecol Obstet. 2009;106:232–5.PubMedCrossRef
12.
go back to reference Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992–1000.PubMedCrossRef Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992–1000.PubMedCrossRef
13.
go back to reference Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–33.PubMedCrossRef Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–33.PubMedCrossRef
14.
go back to reference Obata H, Hayashi N, Motoike Y, et al. A prospective study of development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 1980;25:741–7.PubMedCrossRef Obata H, Hayashi N, Motoike Y, et al. A prospective study of development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 1980;25:741–7.PubMedCrossRef
15.
go back to reference Suen SS, Lao TT, Sahota DS, Lau TK, Leung TY. Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area. J Viral Hepat. 2010;17:372–8.PubMedCrossRef Suen SS, Lao TT, Sahota DS, Lau TK, Leung TY. Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area. J Viral Hepat. 2010;17:372–8.PubMedCrossRef
16.
go back to reference Yeoh EK, Young B, Chan YY, et al. Determinants of immunogenicity and efficacy of hepatitis B vaccine in infants. In: Hollinger FB, Lemon SM, Margolis HS, editors. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins; 1991. Yeoh EK, Young B, Chan YY, et al. Determinants of immunogenicity and efficacy of hepatitis B vaccine in infants. In: Hollinger FB, Lemon SM, Margolis HS, editors. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins; 1991.
17.
go back to reference Gabbuti A, Romanò L, Blanc P, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129–32.PubMedCrossRef Gabbuti A, Romanò L, Blanc P, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129–32.PubMedCrossRef
18.
go back to reference Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25:6958–64.PubMedCrossRef Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25:6958–64.PubMedCrossRef
19.
go back to reference Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed. 1997;77:F47–51.PubMedCrossRef Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed. 1997;77:F47–51.PubMedCrossRef
20.
go back to reference Alfaleh F, Alshehri S, Alansari S, et al. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect. 2008;57:404–9.PubMedCrossRef Alfaleh F, Alshehri S, Alansari S, et al. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect. 2008;57:404–9.PubMedCrossRef
21.
go back to reference Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. J Med Virol. 2007;79:138–43.PubMedCrossRef Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. J Med Virol. 2007;79:138–43.PubMedCrossRef
22.
go back to reference Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan’s national hepatitis B vaccination programme. J Viral Hepat. 2008;15:14–9.PubMed Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan’s national hepatitis B vaccination programme. J Viral Hepat. 2008;15:14–9.PubMed
23.
go back to reference Bialek S, Bower W, Novak R, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth, a 15-year follow up study. Pediatr Infect Dis J. 2008;27:881–5.PubMedCrossRef Bialek S, Bower W, Novak R, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth, a 15-year follow up study. Pediatr Infect Dis J. 2008;27:881–5.PubMedCrossRef
24.
go back to reference Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to HbsAg-positive mothers: a 20-year retrospective study. Infection. 2009;37:340–3.PubMedCrossRef Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to HbsAg-positive mothers: a 20-year retrospective study. Infection. 2009;37:340–3.PubMedCrossRef
25.
go back to reference Young BW, Lee SS, Lim WL, Yeoh EK. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat. 2003;10:23–30.PubMedCrossRef Young BW, Lee SS, Lim WL, Yeoh EK. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat. 2003;10:23–30.PubMedCrossRef
26.
go back to reference Marshall IB. Screening and vaccination for hepatitis B in Hong Kong university students. J Am Coll Health. 1995;44:59–62.PubMedCrossRef Marshall IB. Screening and vaccination for hepatitis B in Hong Kong university students. J Am Coll Health. 1995;44:59–62.PubMedCrossRef
27.
go back to reference Lok AS, Lai CL, Chung HT, Lau JY, Leung EK, Wong LS. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases. Hepatology. 1991;13:834–7.PubMedCrossRef Lok AS, Lai CL, Chung HT, Lau JY, Leung EK, Wong LS. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases. Hepatology. 1991;13:834–7.PubMedCrossRef
28.
go back to reference Wallis DE, Boxall EH. Immunization of infants at risk of perinatal transmission of hepatitis B: retrospective audit of vaccine uptake. Br Med J. 1999;318:1112–3.CrossRef Wallis DE, Boxall EH. Immunization of infants at risk of perinatal transmission of hepatitis B: retrospective audit of vaccine uptake. Br Med J. 1999;318:1112–3.CrossRef
29.
go back to reference Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2009;16:91–3.PubMedCrossRef Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2009;16:91–3.PubMedCrossRef
30.
go back to reference Lee A, Cheng FF, Chan CS, Lau LC, Lo AS. Sero-epidemiology and risk factors of positive hepatitis B surface antigen amongst Chinese adolescents. Asia Pac J Public Health. 2001;13:30–5.PubMedCrossRef Lee A, Cheng FF, Chan CS, Lau LC, Lo AS. Sero-epidemiology and risk factors of positive hepatitis B surface antigen amongst Chinese adolescents. Asia Pac J Public Health. 2001;13:30–5.PubMedCrossRef
31.
go back to reference McMahon B, Bruden D, Petersen K, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15 year follow up. Ann Intern Med. 2008;142:333–41.CrossRef McMahon B, Bruden D, Petersen K, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15 year follow up. Ann Intern Med. 2008;142:333–41.CrossRef
32.
go back to reference Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet. 1989;1:889–93.PubMedCrossRef Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet. 1989;1:889–93.PubMedCrossRef
33.
go back to reference Değertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health. 2000;114:411–2.PubMed Değertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health. 2000;114:411–2.PubMed
34.
go back to reference Ko YC, Yen YY, Yeh SM, Lan SJ. Female to male transmission of hepatitis B virus between Chinese spouses. J Med Virol. 1989;27:142–4.PubMedCrossRef Ko YC, Yen YY, Yeh SM, Lan SJ. Female to male transmission of hepatitis B virus between Chinese spouses. J Med Virol. 1989;27:142–4.PubMedCrossRef
35.
go back to reference Lok AS, Lai CL, Wu PC, Wong VCW, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol. 1987;126:492–9.PubMed Lok AS, Lai CL, Wu PC, Wong VCW, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol. 1987;126:492–9.PubMed
36.
go back to reference Szmuness W, Harley EJ, Prince AM. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci. 1975;270:293–304.PubMedCrossRef Szmuness W, Harley EJ, Prince AM. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci. 1975;270:293–304.PubMedCrossRef
37.
go back to reference Sampliner RE, Loevinger BL, Tabor E, Gerety RJ. Intrafamilial cluster of hepatitis B virus infection: study of a large family in the United States. Am J Epidemiol. 1981;113:50–4.PubMed Sampliner RE, Loevinger BL, Tabor E, Gerety RJ. Intrafamilial cluster of hepatitis B virus infection: study of a large family in the United States. Am J Epidemiol. 1981;113:50–4.PubMed
38.
go back to reference Kashiwagi S, Hayashi J, Ikematsu H, et al. Transmission of hepatitis B virus among siblings. Am J Epidemiol. 1984;120:617–25.PubMed Kashiwagi S, Hayashi J, Ikematsu H, et al. Transmission of hepatitis B virus among siblings. Am J Epidemiol. 1984;120:617–25.PubMed
39.
go back to reference Porres JC, Carreno V, Bartolome J, Gutiez J, Castillo I. A dynamic study of the intrafamilial spread of hepatitis B virus infection: relation with the viral replication. J Med Virol. 1989;28:237–42.PubMedCrossRef Porres JC, Carreno V, Bartolome J, Gutiez J, Castillo I. A dynamic study of the intrafamilial spread of hepatitis B virus infection: relation with the viral replication. J Med Virol. 1989;28:237–42.PubMedCrossRef
40.
go back to reference Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982;146:198–204.PubMedCrossRef Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982;146:198–204.PubMedCrossRef
41.
go back to reference Ucmak H, Faruk Kokoglu O, Celik M, Ergun UG. Intra-familial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infect. 2007;135:1338–43.PubMedCrossRef Ucmak H, Faruk Kokoglu O, Celik M, Ergun UG. Intra-familial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infect. 2007;135:1338–43.PubMedCrossRef
42.
go back to reference Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol. 2005;17:911–5.PubMedCrossRef Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol. 2005;17:911–5.PubMedCrossRef
43.
go back to reference Villarejos VM, Visoná KA, Gutiérrez A, Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974;291:1375–8.PubMedCrossRef Villarejos VM, Visoná KA, Gutiérrez A, Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974;291:1375–8.PubMedCrossRef
44.
go back to reference Scott RM, Snitbhan R, Bancroft WH, Alter HJ, Tingpalapong M. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis. 1980;142:67–71.PubMedCrossRef Scott RM, Snitbhan R, Bancroft WH, Alter HJ, Tingpalapong M. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis. 1980;142:67–71.PubMedCrossRef
45.
go back to reference Inaba N, Ohkawa R, Matsuura A, Kudoh J, Takamizawa H. Sexual transmission of hepatitis B surface antigen infection of husband by HbsAg carrier-state wives. Br J Vener Dis. 1979;55:366–8.PubMed Inaba N, Ohkawa R, Matsuura A, Kudoh J, Takamizawa H. Sexual transmission of hepatitis B surface antigen infection of husband by HbsAg carrier-state wives. Br J Vener Dis. 1979;55:366–8.PubMed
46.
go back to reference Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J Epidemiol Community Health. 1995;49:309–13.PubMedCrossRef Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J Epidemiol Community Health. 1995;49:309–13.PubMedCrossRef
Metadata
Title
Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong
Authors
S. S. H. Suen
T. T. Lao
O. K. Chan
T. K. Lau
T. Y. Leung
P. K. S. Chan
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 2/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0379-6

Other articles of this Issue 2/2013

Infection 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.